Impact of Foods on Bile Acids, Metabolites, and Inflammation
NCT05245357 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2023-05-06
Summary
Dietary incorporation of pulse crops may be an effective way to lower unhealthy elevations in serum bile acids. These elevations play a direct role in promoting obesity-related diseases estimated to be present in about one third of the US adult population, including non-alcoholic fatty liver disease and type 2 diabetes. The overarching hypothesis for this study is that pulse consumption increases bile acid secretion and excretion, which will decrease toxicity linked to excess accumulation of bile in the liver, improve metabolism, and lower resulting levels of bile acids in the serum. In direct alignment with the USDA-AFRI Food, Safety, Nutrition, and Health priority to address obesity and related chronic disease with increased fruit and vegetable consumption and also with the American Pulse Association call to investigate the impact of regular pulse consumption on human physical well- being, the long-term research goal of this study is to establish effective and practical therapeutic strategies utilizing dietary incorporation of pulse crops to prevent or reverse obesity driven diseases. The specific objectives in this proposal are to:
1. determine the impact of acute lentil ingestion on serum postprandial bile acid responses and composition in a human cohort with obesity, and
2. determine the impact of daily lentil consumption for 12 weeks on serum fasting and postprandial bile acid concentrations and composition in an overweight or obese cohort with elevated postprandial triglycerides.
This proposal is being submitted in response to the American Pulse Association commodity board sponsored topic of investigating the impact pulse crop consumption on health.
Conditions
- Inflammation
- Hypertriglyceridemia
- Metabolic Disease
- Lipid Metabolism Disorder
- Hyperlipidemias
- Bile Acid Malabsorption
Interventions
- BEHAVIORAL
-
Lentil
Participants in the lentil arm of the study will consume a meal containing 140 g of lentils for breakfast one morning.
- BEHAVIORAL
-
Control
Participants in the control arm of the study will consume a meal containing 0 g of lentils for breakfast one morning.
Sponsors & Collaborators
-
Montana State University
lead OTHER
Principal Investigators
-
Mary P Miles, PhD · Montana State University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-02-24
- Primary Completion
- 2024-05-31
- Completion
- 2024-05-31
Countries
- United States
Study Locations
More Related Trials
-
Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic Syndrome
NCT06398522 ·Status: COMPLETED ·Phase: NA
-
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
NCT03073343 ·Status: RECRUITING ·Phase: NA
-
Intralumenal Effects on Cholesterol Absorption/Synthesis
NCT00328211 ·Status: COMPLETED ·Phase: NA
-
Impact Of Choline in Patients With NAFLD
NCT05200156 ·Status: UNKNOWN ·Phase: NA
-
Influence of Metabolic Syndrome on Endogenous Oxalate Synthesis
NCT06735924 ·Status: RECRUITING ·Phase: NA
-
Bileacid Malabsorption and GLP-1 Secretion
NCT03009916 ·Status: COMPLETED ·Phase: PHASE4
-
Paternally Inherited Phenotypes in Cholestasis
NCT03337074 ·Status: UNKNOWN
-
Dietary Glycine Supplementation in Metabolic Dysfunction-associated Steatotic Liver Disease
NCT07285135 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis
NCT02557360 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers
NCT03513523 ·Status: COMPLETED ·Phase: NA
-
Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
NCT04073368 ·Status: COMPLETED ·Phase: NA
-
The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 2)
NCT07303868 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus
NCT02871882 ·Status: COMPLETED ·Phase: PHASE2
-
The 8x5 Diet for Bile Acid Diarrhoea: A Feasibility Randomised Controlled Trial
NCT06259396 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis
NCT01998620 ·Status: UNKNOWN ·Phase: PHASE4
-
Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)
NCT00706381 ·Status: COMPLETED ·Phase: PHASE3
-
Zinc Supplementation in Alcoholic Cirrhosis
NCT02072746 ·Status: COMPLETED ·Phase: NA
-
Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease
NCT01016418 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
NCT02787668 ·Status: COMPLETED ·Phase: NA
-
Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis
NCT04175392 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Regulation of FGF21 by Nutritional Challenges
NCT00968747 ·Status: COMPLETED ·Phase: NA
-
The Effect Of Dual Treatment With L-Carnitine And Magnesium On Fatty Liver
NCT01956825 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD
NCT05897606 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition
NCT00004697 ·Status: COMPLETED ·Phase: NA
-
The Effect of an RBAC Supplement (BRM4) on NAFLD
NCT02568787 ·Status: COMPLETED ·Phase: NA